Chargement en cours...
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
Patients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. The outcome is even poorer in patients relapsing after autologous stem cell transplantation. Most of these patients do not qualify for an allogeneic hematopoietic cell transplantation (HCT) due to ref...
Enregistré dans:
| Publié dans: | Hemasphere |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746029/ https://ncbi.nlm.nih.gov/pubmed/31723824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000185 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|